Petmed Express (PETS) closed at $1.19 on October 30, 2026, up 0.8% from the previous close, on volume of 42,261 shares (30-day average 125,133).
Data as of October 30, 2026.
30-Oct-2026
Globe Newswire (Tue, 27-Oct 4:15 PM ET)
PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Fri, 2-Oct 4:05 PM ET)
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
Globe Newswire (Mon, 21-Sep 8:30 AM ET)
PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition
Globe Newswire (Thu, 17-Sep 8:30 AM ET)
PetMeds Appoints Andrew Parry as Chief Technology Officer
Globe Newswire (Mon, 14-Sep 4:05 PM ET)
PetMeds Announces First Quarter Financial Results
Globe Newswire (Thu, 13-Aug 4:05 PM ET)
Market Chameleon (Tue, 30-Jun 6:33 AM ET)
Market Chameleon (Mon, 29-Jun 5:52 AM ET)
PetMeds Unveils Wellness-Focused Holiday Collection Aimed at Health-Conscious Pet Parents
Market Chameleon (Thu, 11-Dec 4:53 AM ET)
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
Petmed Express trades on the NASDAQ stock market under the symbol PETS.
As of October 30, 2026, PETS stock price climbed to $1.19 with 42,261 million shares trading.
PETS has a beta of 1.40, meaning it tends to be more sensitive to market movements. PETS has a correlation of 0.04 to the broad based SPY ETF.
PETS has a market cap of $25.80 million. This is considered a Sub-Micro Cap stock.
Last quarter Petmed Express reported $41 million in Revenue and -$.28 earnings per share. This beat revenue expectation by $31 million and missed earnings estimates by -$.40.
In the last 3 years, PETS traded as high as $8.27 and as low as $1.15.
The top ETF exchange traded funds that PETS belongs to (by Net Assets): VTI, VXF, BSVO, IWC, BUSM.
PETS has underperformed the market in the last year with a return of -52.8%, while the SPY ETF gained +12.3%. In the last 3 month period, PETS fell short of the market, returning -39.9%, while SPY returned +2.1%. However, in the most recent 2 weeks PETS has outperformed the stock market by returning +0.8%, while SPY returned -1.0%.
PETS support price is $1.15 and resistance is $1.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PETS shares will trade within this expected range on the day.